Next-Generation Sequencing – Products

Personalis, Inc. has announced it has partnered with the Academic Breast Cancer Consortium and Criterium to carry out a prospective clinical trial to evaluate the clinical performance of the NeXT Personal® test.

An analysis of NHS prescriptions data has revealed the huge potential for pharmacogenomics to reduce ineffective prescribing and adverse effects, which could save millions of pounds for the NHS.

Sphere Fluidics, a company developing single-cell analysis systems underpinned by its patented picodroplet technology, has announced its involvement in 3DSecret.

From raw data to report, simplify your NGS and CGH data analysis and variant interpretation with integrated bioinformatics for your translational research.

Target enrichment allows researchers to selectively capture, sequence and study specific genes or genomic regions. Carefully designed target enrichment probes that hybridize with high specificity and coverage are essential to ensuring workflow efficiency and data quality.

Agilent Technologies Inc. announced that it will highlight new cell analysis, genomics, digital pathology and companion diagnostics solutions at the American Association for Cancer Research Annual Meeting, held April 14-19, 2023, in Orlando, Florida.

Xyall and Indica Labs have entered into a global strategic partnership designed to bridge the gap between histology and molecular pathology.

Agilent Technologies Inc. has announced the launch of the Agilent SureSelect Cancer CGP Assay designed for somatic variant profiling for a broad range of solid tumor types.

PCR Biosystems has launched a new proofreading polymerase mix for NGS library preparation workflows.

Tecan is excited to introduce its "We can with Tecan" competition, which will recognize the ground-breaking achievements in the field of NGS and reward two winners with their very own MagicPrep™ NGS instruments.